Abstract:The gut microbiota plays an indispensable role in the development and maintenance of both the innate and adaptive immune systems. Alterations in the gut microbiota, or gut dysbiosis, is associated with many autoimmune disorders, including those without gastrointestinal manifestations, such as rheumatoid arthritis and systemic lupus erythematosus (SLE). SLE is a multisystem autoimmune disorder that primarily affects women and is characterized by high rates of hypertension, renal injury, and cardiovascular disease. Recent studies in several animal models have also posited a possible causative role of the gut dysbiosis in the development of hypertension. In the present study, we hypothesized that the gut dysbiosis in SLE may play a role in the development of immune system dysfunction and hypertension in an experimental model of SLE, the NZBWF1 mouse. To test this hypothesis, we treated 18‐week‐old female control (NZW, n=14) and SLE (NZBWF1, n=14) mice with broad spectrum antibiotics (Abx: 0.4 g/L ampicillin, 0.4 g/L neomycin sulfate, 0.4 g/L metronidazole, and 0.2 g/L vancomycin) in drinking water for 16 weeks. Additional groups of control and SLE mice received normal drinking water (control, n=14; SLE, n=14) over the course of the study. At the conclusion of the treatment, we confirmed successful gut microbiome depletion in the feces of control and SLE mice by qPCR of 16S rRNA. Mean arterial pressure (MAP; mmHg), measured in conscious mice by carotid artery catheter, was higher in SLE mice than in control mice (110±4 mmHg control vs. 131±6 mmHg SLE, p<0.01). Unexpectedly, treatment with antibiotics further increased blood pressure in SLE mice (SLE‐Abx: 151±4 mmHg, p<0.01 vs. SLE), but had no impact on blood pressure in control animals (110±4 mmHg control vs. 106±4 mmHg control‐Abx, p=0.91). Urinary albumin excretion, a marker of renal injury, was assessed by ELISA at the conclusion of the study. Albumin excretion was increased in SLE mice (0.22±0.08 mg/day control vs. 25.1±15.7 mg/day SLE, p=0.08), and urinary albumin remained elevated in SLE mice administered antibiotics (43.6±17.3 mg/day, p=0.68 vs. SLE‐Abx). Additionally, renal immune cell infiltration was assessed using flow cytometry. SLE mice had significantly higher levels of renal CD4+ T cells as compared to control mice (0.46±0.04% control vs. 0.84±0.1% SLE, p<0.05), but treatment with antibiotics elevated renal CD4+ T cells further (2.9±0.5%, p<0.001 vs. SLE). An additional pilot study (n=7‐9 mice/group) of short‐term antibiotic treatment from 26‐32 weeks of age had no impact on blood pressure in SLE mice (120±4 mmHg SLE vs. 122±3 mmHg SLE‐Abx, p=0.97). These data suggest that a long‐term loss of the microbiome in SLE actually further exacerbate disease progression and the development of hypertension.

Too Much of a Good Thing: Extended Duration of Gut Microbiota Depletion Reverses Protection From Experimental Autoimmune Uveitis

Increased duration of antibiotic treatment progressively alters gut microbiota and revokes protection from ocular autoimmunity

Gut Microbial Alterations Associated With Protection From Autoimmune Uveitis

Effect Of The Short-Term Use Of Fluoroquinolone And Beta-Lactam Antibiotics On Mouse Gut Microbiota

Gut microbiota as a source of signals that trigger spontaneous ocular autoimmunity.

Severity of Experimental Autoimmune Uveitis Is Reduced by Pretreatment with Live Probiotic Escherichia coli Nissle 1917

Antimetabolite Drugs Exhibit Distinctive Immunomodulatory Mechanisms and Effects on the Intestinal Microbiota in Experimental Autoimmune Uveitis

A combination of inhibiting microglia activity and remodeling gut microenvironment suppresses the development and progression of experimental autoimmune uveitis

Immune Responses to Broad-Spectrum Antibiotic Treatment and Fecal Microbiota Transplantation in Mice

Gut microbiota as a source of a surrogate antigen that triggers autoimmunity in an immune privileged site

Microbiome and Autoimmune Uveitis

Long-term use of ceftriaxone sodium induced changes in gut microbiota and immune system

Exposure of autoimmune uveitis-prone germ-free mice to commensal microbiota promotes development of ocular inflammation

Broad-spectrum antibiotics disrupt homeostatic efferocytosis

Antibiotics-Induced Intestinal Immunomodulation Attenuates Experimental Autoimmune Neuritis (EAN)

Treatment With FoxP3+ Antigen-Experienced T Regulatory Cells Arrests Progressive Retinal Damage in a Spontaneous Model of Uveitis

Association of gut microbiota with spontaneous autoimmune uveitis studied by human flora reconstitution of germ-free mice

Human gut commensals support development of ocular autoimmunity in retina-specific T cell receptor transgenic mice

Long‐term Gut Microbiota Depletion Exacerbates Hypertension and Renal Injury in an Experimental Model of Autoimmune Disease

High salt diet alleviates disease severity in native experimental autoimmune uveitis

Short-term use of ceftriaxone sodium leads to intestinal barrier disruption and ultrastructural changes of kidney in SD rats